Europe Coagulation Market Forecast to 2030

According to the Research Team’ research, the Europe coagulation market was valued at US$ 2,000.64 million in 2022 and is expected to reach US$ 3,379.71 million by 2030, registering a CAGR of 6.8% from 2022 to 2030. Growing organic and inorganic strategies by key market players and increasing prevalence of blood disorders are among the critical factors attributed to the Europe coagulation market expansion.

Changing lifestyle habits and a growing geriatric population are among the major factors increasing the prevalence of blood disorders. Therefore, there is a growing demand for early diagnosis and treatment. Key players are taking several initiatives through various organic and inorganic strategies to enhance the quality of life of patient population.

In June 2021, Trivitron Healthcare introduced NANO H5 and NANO H110, which help in monitoring diabetes, hemoglobin variations, and thalassemia.

In February 2021, Siemens Healthineers and Sysmex Corporation renewed their agreement to supply, distribute, sell, and service hemostasis products across the world. The agreement also included an extension for multiple years. Further, Siemens Healthineers agreed to distribute Sysmex’s automated blood coagulation analyzer, such as the CN-3000 and CN-6000.

In July 2022, HORIBA Medical launched the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a range of convenient ready-to-use reagents for common blood coagulation Offerings. With this expansion of its product line, HORIBA Medical now offers a comprehensive selection of hemostasis systems and advanced reagents for laboratories of all sizes and requirements.

Thus, the adoption of various organic and inorganic strategies by the key market players is expected to provide opportunities for the coagulation market growth during the forecast period

On the contrary, high costs associated with coagulation analyzers hampers the growth Europe coagulation market.

Based on disease indication, the Europe coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand’s disease, and others. The liver disease segment held 54.5% share of the Europe coagulation market in 2022, amassing US$ 1,089.56 million. It is projected to garner US$ 1,816.37 million by 2030 to expand at 6.6% CAGR during 2022-2030.

Based on type, the Europe coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held 68.1% share of the Europe coagulation market in 2022, amassing US$ 1,363.36 million. It is projected to garner US$ 2,209.50 million by 2030 to expand at 6.2% CAGR during 2022-2030. Clinical laboratory analysers is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.

In terms of offering, the Europe coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held 65.4% share of the Europe coagulation market in 2022, amassing US$ 1,308.44 million. It is projected to garner US$ 2,183.42 million by 2030 to expand at 6.6% CAGR during 2022-2030. Diagnosis is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.

By technology, the Europe coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held 60.6% share of Europe coagulation market in 2022, amassing US$ 1,211.83 million. It is projected to garner US$ 2,071.36 million by 2030 to expand at 6.9% CAGR during 2022-2030.

By end user, the Europe coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held 59.7% share of Europe coagulation market in 2022, amassing US$ 1,194.52 million. It is projected to garner US$ 2,047.29 million by 2030 to expand at 7.0% CAGR during 2022-2030.

Based on country, the Europe coagulation market is categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany held 29.7% share of Europe coagulation market in 2022, amassing US$ 593.49 million. It is projected to garner US$ 993.12 million by 2030 to expand at 6.6% CAGR during 2022-2030.

Key players operating in the Europe coagulation market are F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Horiba Ltd; ImproGen Diagnostik Kimya San. & Tic. Ltd.Şti.; Siemens Healthineers AG; Sysmex Corp; Transasia Bio-Medicals Ltd; and Nordic Biomarker AB, among others.

In Feb 2021, Siemens Healthineers and Sysmex Extend Hemostasis Agreement. Siemens Healthineers and Sysmex Corporation announced the renewal of the companies’ long-standing global supply, distributorship, sales and service agreement for a broad portfolio of hemostasis products including a multi-year extension. As part of the agreement Siemens Healthineers will distribute the new Sysmex CN Systems.

In Aug 2021, Siemens Healthineers Launched Sysmex CN-3000 and CN-6000 Hemostasis Systems. This fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories.

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Coagulation Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Increasing Prevalence of Blood Disorders
4.1.2 Rising Prevalence of Cardiovascular Diseases
4.2 Market Restraints
4.2.1 High Costs Associated with Coagulation Analyzers
4.3 Market Opportunities
4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
4.4 Future Trends
4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
4.5 Impact Analysis
5. Coagulation Market – Europe Market Analysis
5.1 Europe Coagulation Market Revenue (US$ million), 2022 – 2030
6. Europe Coagulation Market – Revenue and Forecast to 2030 – by Disease Indication
6.1 Overview
6.2 Europe Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
6.3 Vitamin K Deficiency
6.3.1 Overview
6.3.2 Vitamin K Deficiency: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Liver Disease
6.4.1 Overview
6.4.2 Liver Disease: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
6.5.1 Overview
6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Development of Circulating Anticoagulant
6.6.1 Overview
6.6.2 Development of Circulating Anticoagulant: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.7 Hemophilia
6.7.1 Overview
6.7.2 Hemophilia: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.8 Von Willebrand’s Disease
6.8.1 Overview
6.8.2 Von Willebrand’s Disease: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.9 Others
6.9.1 Overview
6.9.2 Others: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe Coagulation Market – Revenue and Forecast to 2030 – by Type
7.1 Overview
7.2 Europe Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Clinical Laboratory Analyzers
7.3.1 Overview
7.3.2 Clinical Laboratory Analyzers: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Europe Coagulation Market, by Clinical Laboratory Analyzers
7.4 Point-of-Care Testing Analyzers
7.4.1 Overview
7.4.2 Point-of-Care Testing Analyzers: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Coagulation Market – Revenue and Forecast to 2030 – by Offering
8.1 Overview
8.2 Europe Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
8.3 Diagnosis
8.3.1 Overview
8.3.2 Diagnosis: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Europe Coagulation Market, by Diagnosis
8.4 Treatment
8.4.1 Overview
8.4.2 Treatment: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 Europe Coagulation Market, by Treatment
9. Europe Coagulation Market – Revenue and Forecast to 2030 – by Technology
9.1 Overview
9.2 Europe Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
9.3 Optical Technology
9.3.1 Overview
9.3.2 Optical Technology: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Mechanical Technology
9.4.1 Overview
9.4.2 Mechanical Technology: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Electrochemical Technology
9.5.1 Overview
9.5.2 Electrochemical Technology: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Coagulation Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Europe Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Clinical Laboratories
10.3.1 Overview
10.3.2 Clinical Laboratories: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals
10.4.1 Overview
10.4.2 Hospitals: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
11. Europe Coagulation Market – Country Analysis
11.1 Europe Coagulation Market, Revenue and Forecast to 2030
11.1.1 Europe Coagulation Market by Country
11.1.1.1 Germany
11.1.1.1.1 Overview
11.1.1.1.2 Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.1.3 Germany Coagulation Market, by Disease Indication
11.1.1.1.4 Germany Coagulation Market, by Type
11.1.1.1.4.1 Germany Coagulation Market, by Clinical Laboratory Analyzers
11.1.1.1.5 Germany Coagulation Market, by Offering
11.1.1.1.5.1 Germany Coagulation Market, by Diagnosis
11.1.1.1.5.2 Germany Coagulation Market, by Treatment
11.1.1.1.6 Germany Coagulation Market, by Technology
11.1.1.1.7 Germany Coagulation Market, by End User
11.1.1.2 UK
11.1.1.2.1 Overview
11.1.1.2.1.1 UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.2.2 UK Coagulation Market, by Disease Indication
11.1.1.2.3 UK Coagulation Market, by Type
11.1.1.2.3.1 UK Coagulation Market, by Clinical Laboratory Analyzers
11.1.1.2.4 UK Coagulation Market, by Offering
11.1.1.2.4.1 UK Coagulation Market, by Diagnosis
11.1.1.2.4.2 UK Coagulation Market, by Treatment
11.1.1.2.5 UK Coagulation Market, by Technology
11.1.1.2.6 UK Coagulation Market, by End User
11.1.1.3 France
11.1.1.3.1 Overview
11.1.1.3.1.1 France Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.3.2 France Coagulation Market, by Disease Indication
11.1.1.3.3 France Coagulation Market, by Type
11.1.1.3.3.1 France Coagulation Market, by Clinical Laboratory Analyzers
11.1.1.3.4 France Coagulation Market, by Offering
11.1.1.3.4.1 France Coagulation Market, by Diagnosis
11.1.1.3.4.2 France Coagulation Market, by Treatment
11.1.1.3.5 France Coagulation Market, by Technology
11.1.1.3.6 France Coagulation Market, by End User
11.1.1.4 Italy
11.1.1.4.1 Overview
11.1.1.4.1.1 Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.4.2 Italy Coagulation Market, by Disease Indication
11.1.1.4.3 Italy Coagulation Market, by Type
11.1.1.4.3.1 Italy Coagulation Market, by Clinical Laboratory Analyzers
11.1.1.4.4 Italy Coagulation Market, by Offering
11.1.1.4.4.1 Italy Coagulation Market, by Diagnosis
11.1.1.4.4.2 Italy Coagulation Market, by Treatment
11.1.1.4.5 Italy Coagulation Market, by Technology
11.1.1.4.6 Italy Coagulation Market, by End User
11.1.1.5 Spain
11.1.1.5.1 Overview
11.1.1.5.2 Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.5.3 Spain Coagulation Market, by Disease Indication
11.1.1.5.4 Spain Coagulation Market, by Type
11.1.1.5.4.1 Spain Coagulation Market, by Clinical Laboratory Analyzers
11.1.1.5.5 Spain Coagulation Market, by Offering
11.1.1.5.5.1 Spain Coagulation Market, by Diagnosis
11.1.1.5.5.2 Spain Coagulation Market, by Treatment
11.1.1.5.6 Spain Coagulation Market, by Technology
11.1.1.5.7 Spain Coagulation Market, by End User
11.1.1.6 Rest of Europe
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.6.3 Rest of Europe Coagulation Market, by Disease Indication
11.1.1.6.4 Rest of Europe Coagulation Market, by Type
11.1.1.6.4.1 Rest of Europe Coagulation Market, by Clinical Laboratory Analyzers
11.1.1.6.5 Rest of Europe Coagulation Market, by Offering
11.1.1.6.5.1 Rest of Europe Coagulation Market, by Diagnosis
11.1.1.6.5.2 Rest of Europe Coagulation Market, by Treatment
11.1.1.6.6 Rest of Europe Coagulation Market, by Technology
11.1.1.6.7 Rest of Europe Coagulation Market, by End User
12. Europe Coagulation Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Coagulation Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Siemens Healthineers AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.Şti.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Nordic Biomarker AB
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sysmex Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Genrui Biotech Co., Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Transasia Bio-Medicals Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Horiba Ltd.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

Table 1. Europe Coagulation Market Segmentation
Table 2. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 3. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 4. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 5. Optical Technologies and Their Applications
Table 6. Mechanical Technologies and Their Applications
Table 7. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 8. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 9. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 10. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 11. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 12. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 13. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 14. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 15. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 16. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 17. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 18. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 19. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 20. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 21. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 22. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 23. France Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 24. France Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 25. France Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 26. France Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 27. France Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 28. France Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 29. France Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 30. France Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 31. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 32. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 33. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 34. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 35. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 36. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 37. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 38. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 39. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 40. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 41. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 42. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 43. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 44. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 45. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 46. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 47. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 48. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 49. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 50. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 51. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 52. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 53. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 54. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 55. Recent Inorganic Growth Strategies in the Coagulation Market
Table 56. Recent Organic Growth Strategies in the Coagulation Market
Table 57. Glossary of Terms, Coagulation Market

Figure 1. Europe Coagulation Market Segmentation, By Country
Figure 2. Europe Coagulation Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Coagulation Market Revenue (US$ million), 2020 – 2030
Figure 5. Europe Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 6. Vitamin K Deficiency: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liver Disease: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Development of Circulating Anticoagulant: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hemophilia: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Von Willebrand’s Disease: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
Figure 14. Clinical Laboratory Analyzers: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Point-of-Care Testing Analyzers: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
Figure 17. Diagnosis: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Treatment: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 20. Optical Technology: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mechanical Technology: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Electrochemical Technology: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Europe Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 25. Clinical Laboratories: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Hospitals: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Others: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Europe Coagulation Market, By Geography, 2022 ($million)
Figure 29. Europe Coagulation Market, By Key Countries, 2022 and 2030 (%)
Figure 30. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 31. UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 32. France Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 33. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 34. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 35. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 36. Growth Strategies in the Coagulation Market